Lagevrio

molnupiravir

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Lagevrio, covering 2021-11-19 to 2023-08-09. Get the full timeline:

Most recent: EMA Application withdrawn: Lagevrio (molnupiravir) — Merck Sharp & Dohme B.V.